Creating a immune-cloaked allogenic skin product for extensive wound repair☆
|AFFILIATION:||Propagenix Inc., Rockville, Maryland, United States|
Track: Medical & Biotech
Area: Regenerative Medicine
Tech Readiness: TRL 3
Tech Brief: Skin transplants to repair wounds typically requires slicing healthy skin from uninjured areas. Our technology will provide a transportable artificial human skin product that avoids taking skin from the patient, is not rejected by the patient's immune system, and regenerates due to skin stem cells in the product.
Value Proposition: The ability to repair battlefield wounds with a ready-to-use skin product that represents normal primary skin stem cells (not a immortalized cell line) and which also does not get rejected by the patient's immune system offers a unique approach to battlefield injury medicine. The fact that Propagenix technology can generate a near unlimited supply of skin cells removes the limitation of supply, therapeutic staging, and the pain associated with graft collection that comes with autologous skin grafting.
Org Type: Mid-stage Startup (A or B)
Booth Number: T410